Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Apr;20(4):203-217.
doi: 10.1038/s41568-020-0246-1. Epub 2020 Mar 11.

Inflammatory microenvironment remodelling by tumour cells after radiotherapy

Martin McLaughlin  1 , Emmanuel C Patin  2 , Malin Pedersen  3 , Anna Wilkins  4 , Magnus T Dillon  2   4 , Alan A Melcher  3   4 , Kevin J Harrington  2   4
Affiliations
Review

Inflammatory microenvironment remodelling by tumour cells after radiotherapy

Martin McLaughlin et al. Nat Rev Cancer. 2020 Apr.

Abstract

The development of immune checkpoint inhibitors (ICIs) is revolutionizing the way we think about cancer treatment. Even so, for most types of cancer, only a minority of patients currently benefit from ICI therapies. Intrinsic and acquired resistance to ICIs has focused research towards new combination therapy approaches that seek to increase response rates, the depth of remission and the durability of benefit. In this Review, we describe how radiotherapy, through its immunomodulating effects, represents a promising combination partner with ICIs. We describe how recent research on DNA damage response (DDR) inhibitors in combination with radiotherapy may be used to augment this approach. Radiotherapy can kill cancer cells while simultaneously triggering the release of pro-inflammatory mediators and increasing tumour-infiltrating immune cells - phenomena often described colloquially as turning immunologically 'cold' tumours 'hot'. Here, we focus on new developments illustrating the key role of tumour cell-autonomous signalling after radiotherapy. Radiotherapy-induced tumour cell micronuclei activate cytosolic nucleic acid sensor pathways, such as cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING), and propagation of the resulting inflammatory signals remodels the immune contexture of the tumour microenvironment. In parallel, radiation can impact immunosurveillance by modulating neoantigen expression. Finally, we highlight how tumour cell-autonomous mechanisms might be exploited by combining DDR inhibitors, ICIs and radiotherapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Delaney, G., Jacob, S., Featherstone, C. & Barton, M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 104, 1129–1137 (2005). - PubMed - DOI
    1. Formenti, S. C. et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade. Nat. Med. 24, 1845–1851 (2018). This study reports the induction of systemic antitumour T cells in metastatic NSCLC by radiation therapy and CTLA4 blockade. This was observed in chemo-refractory patients where anti-CTLA4 alone failed to demonstrate significant efficacy. - PubMed - PMC - DOI
    1. Antonia, S. J. et al. Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. N. Engl. J. Med. 379, 2342–2350 (2018). - PubMed - DOI
    1. Dillon, M. T. et al. Radiosensitization by the ATR inhibitor AZD6738 through generation of acentric micronuclei. Mol. Cancer Ther. 16, 25–34 (2017). - PubMed - DOI
    1. Harding, S. M. et al. Mitotic progression following DNA damage enables pattern recognition within micronuclei. Nature 548, 466–470 (2017). - PubMed - PMC - DOI

Publication types

MeSH terms

LinkOut - more resources